Salvaging Detection of Early-Stage Ovarian Malignancies When CA-125 Is Not Informative
The paper discusses methods to improve early-stage ovarian malignancy detection when CA-125 is not informative, using a multivariate index assay.
Read MoreMultivariate Index Assay Is Superior to CA-125 and HE4 Testing in Detection of Ovarian Malignancy in African-American Women
This study shows the superiority of the multivariate index assay over CA125 and HE4 tests in detecting ovarian malignancies in African-American women.
Read MoreEconomic Impact of Increased Utilization of Multivariate Assay Testing to Guide the Treatment of Ovarian Cancer: Implications for Payers
The results of the budget impact model support the use of OVA1 instead of CA125 by indicating that modest cost-savings can be achieved, while reaping the clinical benefits of improved diagnostic accuracy, early disease detection, and reductions in multiple, and possibly unnecessary, referrals to gynecologic oncologists
Read More